Artículos de revistas sobre el tema "YAP/TEAD COMPLEX"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "YAP/TEAD COMPLEX".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Pobbati, Ajaybabu V. y Brian P. Rubin. "Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex". Molecules 25, n.º 24 (18 de diciembre de 2020): 6001. http://dx.doi.org/10.3390/molecules25246001.
Texto completoKim, Jisook, Seung Hyun Jung, Seon Yeong Han, Jihee Yoon, Minjeong Kim, Jooyun Byun, Heesun Moon et al. "Abstract 1614: Antitumor activity of novel and potent YAP/TAZ-TEAD inhibitorstargeting the Hippo pathway in solid tumors". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 1614. http://dx.doi.org/10.1158/1538-7445.am2023-1614.
Texto completoMoure, Casey J., Christopher Sondey, Mangeng Cheng, My Mansueto, Rafael Fernandez, Sebastian E. Schneider, Julia V. Ramirez et al. "Abstract 3938: Discovery of a novel small molecule inhibitor of the YAP1/TAZ-TEAD transcriptional complex". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3938. http://dx.doi.org/10.1158/1538-7445.am2022-3938.
Texto completoLi, Z., B. Zhao, P. Wang, F. Chen, Z. Dong, H. Yang, K. L. Guan y Y. Xu. "Structural insights into the YAP and TEAD complex". Genes & Development 24, n.º 3 (1 de febrero de 2010): 235–40. http://dx.doi.org/10.1101/gad.1865810.
Texto completoLauriola, Angela, Elisa Uliassi, Matteo Santucci, Maria Laura Bolognesi, Marco Mor, Laura Scalvini, Gian Marco Elisi et al. "Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library". Pharmaceutics 14, n.º 2 (10 de febrero de 2022): 391. http://dx.doi.org/10.3390/pharmaceutics14020391.
Texto completoSheldon, Caroline, Aaron Farley, Qing Ma, William T. Pu y Zhiqiang Lin. "Depletion of VGLL4 Causes Perinatal Lethality without Affecting Myocardial Development". Cells 11, n.º 18 (10 de septiembre de 2022): 2832. http://dx.doi.org/10.3390/cells11182832.
Texto completoKim, Eui Hyun y Seok-Gu Kang. "CSIG-25. DIFFERENTIAL YAP ACTIVITY IN HUMAN GLIOBLASTOMA TUMORSPHERES AS A POTENTIAL BIOMARKER". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii44. http://dx.doi.org/10.1093/neuonc/noac209.174.
Texto completoKim, Cho-Long, Yu-Su Shin, Sue-Hee Choi, Seroc Oh, Kyeongseob Kim, Han-Sol Jeong y Jung-Soon Mo. "Extracts of Perilla frutescens var. Acuta (Odash.) Kudo Leaves Have Antitumor Effects on Breast Cancer Cells by Suppressing YAP Activity". Evidence-Based Complementary and Alternative Medicine 2021 (15 de febrero de 2021): 1–13. http://dx.doi.org/10.1155/2021/5619761.
Texto completode Andrade, Leonardo Guedes, Valério Marques Portela, Esdras Corrêa Dos Santos, Karine de Vargas Aires, Rogério Ferreira, Daniele Missio, Zigomar da Silva et al. "FSH Regulates YAP-TEAD Transcriptional Activity in Bovine Granulosa Cells to Allow the Future Dominant Follicle to Exert Its Augmented Estrogenic Capacity". International Journal of Molecular Sciences 23, n.º 22 (16 de noviembre de 2022): 14160. http://dx.doi.org/10.3390/ijms232214160.
Texto completoCheng, Wen-Chih, Osnat Bohana-Kashtan, Sebastien Morisot, Nailing Zhang, Qian Chen, Duojia Pan y Curt I. Civin. "The YAP Transcriptional Co-Activator Is Not Required for Mouse Hematopoiesis, at Steady State or After 5FU Treatment." Blood 116, n.º 21 (19 de noviembre de 2010): 1592. http://dx.doi.org/10.1182/blood.v116.21.1592.1592.
Texto completoShen, Hongling, Xiaofeng Xu, Hongfei Rong, Xizhen Song, Jinheng Gao, Jie Chen, Di Zhu et al. "Abstract 501: Discovery of BPI-460372, a potent and selective inhibitor of TEAD for the treatment of solid tumors harboring Hippo pathway aberrations". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 501. http://dx.doi.org/10.1158/1538-7445.am2023-501.
Texto completoGnedeva, Ksenia, Xizi Wang, Melissa M. McGovern, Matthew Barton, Litao Tao, Talon Trecek, Tanner O. Monroe et al. "Organ of Corti size is governed by Yap/Tead-mediated progenitor self-renewal". Proceedings of the National Academy of Sciences 117, n.º 24 (1 de junio de 2020): 13552–61. http://dx.doi.org/10.1073/pnas.2000175117.
Texto completoOrtega, Ángel, Ivana Vera, Maria Diaz, Carla Navarro, Milagros Rojas, Wheeler Torres, Heliana Parra, Juan Salazar, Juan De Sanctis y Valmore Bermúdez. "The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises". International Journal of Molecular Sciences 23, n.º 1 (31 de diciembre de 2021): 430. http://dx.doi.org/10.3390/ijms23010430.
Texto completoChe, Kepeng, Ajaybabu V. Pobbati, Caleb N. Seavey, Yuriy Fedorov, Anton A. Komar, Ashley Burtscher, Shuang Ma y Brian P. Rubin. "Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex". PLOS ONE 17, n.º 4 (13 de abril de 2022): e0266143. http://dx.doi.org/10.1371/journal.pone.0266143.
Texto completoZhang, Dingwa, Deyong He, Xiaoliang Pan y Lijun Liu. "Rational Design and Intramolecular Cyclization of Hotspot Peptide Segments at YAP–TEAD4 Complex Interface". Protein & Peptide Letters 27, n.º 10 (2 de noviembre de 2020): 999–1006. http://dx.doi.org/10.2174/0929866527666200414160723.
Texto completoBhat, Krishna, Krishna Bhat y Tiffany Tang. "DNAR-05. A ROLE FOR TAZ/YAP IN DNA DAMAGE REPAIR IN GLIOBLASTOMA". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii91. http://dx.doi.org/10.1093/neuonc/noac209.337.
Texto completoLiu-Chittenden, Y., B. Huang, J. S. Shim, Q. Chen, S. J. Lee, R. A. Anders, J. O. Liu y D. Pan. "Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP". Genes & Development 26, n.º 12 (7 de junio de 2012): 1300–1305. http://dx.doi.org/10.1101/gad.192856.112.
Texto completoKamal, Adeela, Aurélie Candi, Matthias Versele, Bart Vanderhoydonck, Arnaud Marchand, Ron de Jong, Thuy Hoang et al. "Abstract 3945: Novel antagonists of TEAD palmitoylation inhibit the growth of Hippo-altered cancers in preclinical models". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3945. http://dx.doi.org/10.1158/1538-7445.am2022-3945.
Texto completoRogg, Manuel, Jasmin I. Maier, Martin Helmstädter, Alena Sammarco, Felix Kliewe, Oliver Kretz, Lisa Weißer et al. "A YAP/TAZ–ARHGAP29–RhoA Signaling Axis Regulates Podocyte Protrusions and Integrin Adhesions". Cells 12, n.º 13 (6 de julio de 2023): 1795. http://dx.doi.org/10.3390/cells12131795.
Texto completoKim, Jongwan, Hocheol Lim, Sungho Moon, Seon Yeon Cho, Minhye Kim, Jae Hyung Park, Hyun Woo Park y Kyoung Tai No. "Hot Spot Analysis of YAP-TEAD Protein-Protein Interaction Using the Fragment Molecular Orbital Method and Its Application for Inhibitor Discovery". Cancers 13, n.º 16 (23 de agosto de 2021): 4246. http://dx.doi.org/10.3390/cancers13164246.
Texto completoHuang, Yunying, Usama Sharif Ahmad, Ambreen Rehman, Jutamas Uttagomol y Hong Wan. "YAP Inhibition by Verteporfin Causes Downregulation of Desmosomal Genes and Proteins Leading to the Disintegration of Intercellular Junctions". Life 12, n.º 6 (26 de mayo de 2022): 792. http://dx.doi.org/10.3390/life12060792.
Texto completoLi, Jie Jack, Guiping Zhang y Jiapeng Li. "Abstract 3401: Discovery of GH658, a novel tead allosteric inhibitor as a cancer therapy". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 3401. http://dx.doi.org/10.1158/1538-7445.am2023-3401.
Texto completoZhang, Wenxiang, Jinjin Xu, Jinhui Li, Tong Guo, Dan Jiang, Xue Feng, Xueyan Ma et al. "The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex". Journal of Biological Chemistry 293, n.º 44 (12 de septiembre de 2018): 17119–34. http://dx.doi.org/10.1074/jbc.ra118.003608.
Texto completoQiao, Y., S. J. Lin, Y. Chen, D. C.-C. Voon, F. Zhu, L. S. H. Chuang, T. Wang et al. "RUNX3 is a novel negative regulator of oncogenic TEAD–YAP complex in gastric cancer". Oncogene 35, n.º 20 (14 de septiembre de 2015): 2664–74. http://dx.doi.org/10.1038/onc.2015.338.
Texto completoChen, Liming, Portia Gloria Loh y Haiwei Song. "Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway". Protein & Cell 1, n.º 12 (diciembre de 2010): 1073–83. http://dx.doi.org/10.1007/s13238-010-0138-3.
Texto completoChien, Chu-Yen, Ying-Chen Chen, Chia-Chen Hsu, Yu-Ting Chou, Shine-Gwo Shiah, Shyun-Yeu Liu, Alexander Cheng-Ting Hsieh, Ching-Yu Yen, Chien-Hsing Lee y Yi-Shing Shieh. "YAP-Dependent BiP Induction Is Involved in Nicotine-Mediated Oral Cancer Malignancy". Cells 10, n.º 8 (13 de agosto de 2021): 2080. http://dx.doi.org/10.3390/cells10082080.
Texto completoKohli, Priyanka, Malte P. Bartram, Sandra Habbig, Caroline Pahmeyer, Tobias Lamkemeyer, Thomas Benzing, Bernhard Schermer y Markus M. Rinschen. "Label-free quantitative proteomic analysis of the YAP/TAZ interactome". American Journal of Physiology-Cell Physiology 306, n.º 9 (1 de mayo de 2014): C805—C818. http://dx.doi.org/10.1152/ajpcell.00339.2013.
Texto completoSudhir, Sweta, Maria Anastasiadou, Gabrielle Price y Constantinos Hadjipanayis. "CSIG-18. ANTI-TUMOR EFFECTS OF VERTEPORFIN AND PHOTODYNAMIC THERAPY IN COMBINATION WITH STANDARD OF CARE ON PATIENT-DERIVED GBM CELL LINES". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii42—vii43. http://dx.doi.org/10.1093/neuonc/noac209.167.
Texto completoChen, Jianchun, Huaizhou You, Yan Li, You Xu, Qian He y Raymond C. Harris. "EGF Receptor–Dependent YAP Activation Is Important for Renal Recovery from AKI". Journal of the American Society of Nephrology 29, n.º 9 (2 de agosto de 2018): 2372–85. http://dx.doi.org/10.1681/asn.2017121272.
Texto completoLi, Zhengyu, Juntao Feng, Jinhai Gou, Jia Jia, Tao Yi y Tao Cui. "Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer". OncoTargets and Therapy Volume 9 (agosto de 2016): 5371–81. http://dx.doi.org/10.2147/ott.s109979.
Texto completoClattenburg, Leanne, Michael Wigerius, Jiansong Qi, Jan K. Rainey, Jillian L. Rourke, Shanmugam Muruganandan, Christopher J. Sinal y James P. Fawcett. "NOS1AP Functionally Associates with YAP To Regulate Hippo Signaling". Molecular and Cellular Biology 35, n.º 13 (27 de abril de 2015): 2265–77. http://dx.doi.org/10.1128/mcb.00062-15.
Texto completoWolfe, Andrew L., Qingwen Zhou, Eneda Toska, Jacqueline Galeas, Angel A. Ku, Richard P. Koche, Sourav Bandyopadhyay et al. "UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth". Proceedings of the National Academy of Sciences 118, n.º 31 (30 de julio de 2021): e2103592118. http://dx.doi.org/10.1073/pnas.2103592118.
Texto completoZhou, Xiangxiang, Juan Yang, Ya Zhang, Ying Li, Xiaosheng Fang, Na Chen y Xin Wang. "Blockade of Yes-Associated Protein As a Novel Therapeutic Approach in Diffuse Large B-Cell Lymphoma". Blood 134, Supplement_1 (13 de noviembre de 2019): 808. http://dx.doi.org/10.1182/blood-2019-129695.
Texto completoCunningham, Richard y Carsten Gram Hansen. "The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer". Clinical Science 136, n.º 3 (febrero de 2022): 197–222. http://dx.doi.org/10.1042/cs20201474.
Texto completoBokhovchuk, Fedir, Yannick Mesrouze, Marco Meyerhofer, Catherine Zimmermann, Patrizia Fontana, Dirk Erdmann, Per Jemth y Patrick Chène. "An Early Association between the α-Helix of the TEAD Binding Domain of YAP and TEAD Drives the Formation of the YAP:TEAD Complex". Biochemistry 59, n.º 19 (24 de abril de 2020): 1804–12. http://dx.doi.org/10.1021/acs.biochem.0c00217.
Texto completoBi-Lin, Kathleen Wung, Pratap Veerabrahma Seshachalam, Tran Tuoc, Anastassia Stoykova, Sujoy Ghosh y Manvendra K. Singh. "Critical role of the BAF chromatin remodeling complex during murine neural crest development". PLOS Genetics 17, n.º 3 (22 de marzo de 2021): e1009446. http://dx.doi.org/10.1371/journal.pgen.1009446.
Texto completoSileo, Pasquale, Clémence Simonin, Patricia Melnyk, Marie-Christine Chartier-Harlin y Philippe Cotelle. "Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington’s Disease and Other Neurodegenerative Disorders". Cells 11, n.º 22 (16 de noviembre de 2022): 3631. http://dx.doi.org/10.3390/cells11223631.
Texto completoKaushik, Itishree, Shreyas Gaikwad y Sanjay K. Srivastava. "Abstract 3895: Moxidectin unravels the role of Hippo-YAP pathway in maintaining immunity of pediatric glioblastoma". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3895. http://dx.doi.org/10.1158/1538-7445.am2022-3895.
Texto completoWei, Honglong, Fuhai Wang, Yong Wang, Tao Li, Peng Xiu, Jingtao Zhong, Xueying Sun y Jie Li. "Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex". Cancer Science 108, n.º 3 (marzo de 2017): 478–87. http://dx.doi.org/10.1111/cas.13138.
Texto completoZhang, Wenjing, Yijun Gao, Peixue Li, Zhubing Shi, Tong Guo, Fei Li, Xiangkun Han et al. "VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex". Cell Research 24, n.º 3 (24 de enero de 2014): 331–43. http://dx.doi.org/10.1038/cr.2014.10.
Texto completoZhou, X., X. Fang, N. Chen, K. Lu, X. Lv y X. Wang. "THE PHOTOSENSITIZER VERTEPORFIN EXERTED ANTI-TUMOR EFFECT IN DIFFUSE LARGE B-CELL LYMPHOMA VIA DISRUPTING YAP-TEAD COMPLEX". Hematological Oncology 37 (junio de 2019): 514. http://dx.doi.org/10.1002/hon.198_2631.
Texto completoPijuan-Galitó, Sara, Christoffer Tamm y Cecilia Annerén. "Serum Inter-α-inhibitor Activates the Yes Tyrosine Kinase and YAP/TEAD Transcriptional Complex in Mouse Embryonic Stem Cells". Journal of Biological Chemistry 289, n.º 48 (9 de octubre de 2014): 33492–502. http://dx.doi.org/10.1074/jbc.m114.580076.
Texto completoGibault, Floriane, Manon Sturbaut, Mathilde Coevoet, Martine Pugnière, Ashley Burtscher, Frédéric Allemand, Patricia Melnyk et al. "Design, Synthesis and Evaluation of a Series of 1,5‐Diaryl‐1,2,3‐triazole‐4‐carbohydrazones as Inhibitors of the YAP‐TAZ/TEAD Complex". ChemMedChem 16, n.º 18 (julio de 2021): 2823–44. http://dx.doi.org/10.1002/cmdc.202100153.
Texto completoBaitei, Essa Y., Min Zhang, Qianqian Sun, Jin-Li Luo, Philip Zhang, Tamihiro Kamata, James Harber et al. "Abstract 6086: Clonal biallelic inactivation of NF2 is an evolutionary bottleneck that exposes a vulnerability to CDK7 inhibition in mesothelioma". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 6086. http://dx.doi.org/10.1158/1538-7445.am2022-6086.
Texto completoAsimomitis, George, André G. Deslauriers, Andriana G. Kotini, Elsa Bernard, Davide Esposito, Malgorzata Olszewska, Nikolaos Spyrou et al. "Isogenic MDS-RS Patient-Derived iPSCs Define the Mis-Spliced Transcript Repertoire and Chromatin Landscape of SF3B1-Mutant Hematopoietic Stem/Progenitor Cells". Blood 138, Supplement 1 (5 de noviembre de 2021): 147. http://dx.doi.org/10.1182/blood-2021-149830.
Texto completoGao, Yunan, Yan Sun, Adife Gulhan Ercan-Sencicek, Justin S. King, Brynn N. Akerberg, Qing Ma, Maria I. Kontaridis, William T. Pu y Zhiqiang Lin. "YAP/TEAD1 Complex Is a Default Repressor of Cardiac Toll-Like Receptor Genes". International Journal of Molecular Sciences 22, n.º 13 (22 de junio de 2021): 6649. http://dx.doi.org/10.3390/ijms22136649.
Texto completoKadamb, Rama, Melisa Lopez Anton, Vivian Chua, Timothy Purwin, Maria Angelo Nieto Toledano, Andrew Aplin y Julio Aguirre-Ghiso. "Abstract A009: NR2F1 inhibits Gaq/11-YAP-TAZ signaling and limits reactivation of uveal melanoma disseminated cancer cells via induction of dormancy". Cancer Research 83, n.º 2_Supplement_2 (15 de enero de 2023): A009. http://dx.doi.org/10.1158/1538-7445.metastasis22-a009.
Texto completoMougel, G., G. Mondielli, R. Appay, A. Querdray, C. Roche, A. Jijon, I. Konstantinova, A. Soude, T. Graillon y A. Barlier. "P18.07.A Hippo signaling pathway is strongly involved in meningioma tumorigenesis". Neuro-Oncology 24, Supplement_2 (1 de septiembre de 2022): ii95. http://dx.doi.org/10.1093/neuonc/noac174.334.
Texto completoSong, Yong, Jing Fu, Min Zhou, Li Xiao, Xue Feng, Hengxi Chen y Wei Huang. "Activated Hippo/Yes-Associated Protein Pathway Promotes Cell Proliferation and Anti-apoptosis in Endometrial Stromal Cells of Endometriosis". Journal of Clinical Endocrinology & Metabolism 101, n.º 4 (1 de abril de 2016): 1552–61. http://dx.doi.org/10.1210/jc.2016-1120.
Texto completoEisinger-Mathason, T. S. Karin, Vera Mucaj, Kevin M. Biju, Michael S. Nakazawa, Mercy Gohil, Timothy P. Cash, Sam S. Yoon et al. "Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis". Proceedings of the National Academy of Sciences 112, n.º 26 (15 de junio de 2015): E3402—E3411. http://dx.doi.org/10.1073/pnas.1420005112.
Texto completo